proceedings:2023_igorr21
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| proceedings:2023_igorr21 [2025/12/09 15:18] – Bruno Baumeister | proceedings:2023_igorr21 [2025/12/09 15:43] (current) – Bruno Baumeister | ||
|---|---|---|---|
| Line 5: | Line 5: | ||
| < | < | ||
| ^ Number ^ Title ^ Author(s) ^ | ^ Number ^ Title ^ Author(s) ^ | ||
| - | |**__Plenary | + | |**__Plenary |
| - | |01| {{ : | + | |01| {{ : |
| - | |02| {{ : | + | |02| {{ : |
| - | |05| {{ : | + | |05| {{ : |
| - | |**__Session 1: NIST__**||| | + | |**__Session 1: NIST (Monday 19 June 2023)__**||| |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 15: | Line 15: | ||
| |04| {{ : | |04| {{ : | ||
| |05| {{ : | |05| {{ : | ||
| - | |**__Session 2: New and Advanced Reactors | + | |**__Session 2: New and Advanced Reactors |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 22: | Line 22: | ||
| |05| {{ : | |05| {{ : | ||
| |06| {{ : | |06| {{ : | ||
| - | |**__Session 3: Experiments | + | |**__Session 3: Experiments |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 29: | Line 29: | ||
| |05| {{ : | |05| {{ : | ||
| |06| {{ : | |06| {{ : | ||
| - | |**__Session 4: Safety and Security__**||| | + | |**__Session 4: Safety and Security (Monday 19 June 2023)__**||| |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 35: | Line 35: | ||
| |04| {{ : | |04| {{ : | ||
| |05| {{ : | |05| {{ : | ||
| - | |**__Session 5: Fuel Cycle / Instrumentation__**||| | + | |**__Session 5: Fuel Cycle / Instrumentation (Monday 19 June 2023)__**||| |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| - | |03| {{ : | + | |04| {{ : |
| - | |04| {{ : | + | |05| {{ : |
| - | |**__Session 6: Operations and Maintenance | + | |**__Session 6: Operations and Maintenance |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 46: | Line 46: | ||
| |04| {{ : | |04| {{ : | ||
| |05| {{ : | |05| {{ : | ||
| - | |**__Session 7: Utilization / Experiments | + | |**__Session 7: Utilization / Experiments |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 52: | Line 52: | ||
| |04| {{ : | |04| {{ : | ||
| |05| {{ : | |05| {{ : | ||
| - | |**__Session 8: Computer | + | |**__Session 8: Computer |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 58: | Line 58: | ||
| |04| {{ : | |04| {{ : | ||
| |05| {{ : | |05| {{ : | ||
| - | |**__Session 9: New and Advanced Reactors | + | |**__Session 9: New and Advanced Reactors |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 66: | Line 66: | ||
| |06| {{ : | |06| {{ : | ||
| |07| {{ : | |07| {{ : | ||
| - | |**__Session 10: Common Management Considerations / Decommissioning__**||| | + | |**__Session 10: Common Management Considerations / Decommissioning (Tuesday 20 June 2023)__**||| |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 74: | Line 74: | ||
| |06| {{ : | |06| {{ : | ||
| |07| {{ : | |07| {{ : | ||
| - | |**__Session 11: Operations and Maintenance | + | |**__Session 11: Operations and Maintenance |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| |03| {{ : | |03| {{ : | ||
| - | |04| {{ : | + | |04| {{ : |
| - | |**__Session 12: Refurbishment Methods / Innovative | + | |**__Session 12: Refurbishment Methods / Innovative |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| Line 85: | Line 85: | ||
| |04| {{ : | |04| {{ : | ||
| |05| {{ : | |05| {{ : | ||
| - | |**__Session 13: NRC Plenary | + | |**__Session 13: NRC Plenary |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| - | |**__Session 14: Operations and Maintenance | + | |**__Session 14: Operations and Maintenance |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| |03| {{ : | |03| {{ : | ||
| |04| {{ : | |04| {{ : | ||
| - | |**__Session 15: Diversity and Inclusion | + | |**__Session 15: Diversity and Inclusion |
| - | |01| {{ : | + | |01| {{ : |
| - | |**__Session 16: Medical Isotope Production | + | |**__Session 16: Medical Isotope Production |
| |01| {{ : | |01| {{ : | ||
| |02| {{ : | |02| {{ : | ||
| |03| {{ : | |03| {{ : | ||
| + | |**__Other presentations__**||| | ||
| + | |01| {{ : | ||
| + | |02| {{ : | ||
| </ | </ | ||
proceedings/2023_igorr21.1765289904.txt.gz · Last modified: by Bruno Baumeister
